Claret Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Claret Asset Management's AMGN Position: Q1 2026 in Review
Claret Asset Management reduced its Amgen (AMGN) stake by 0.29% in Q1 2026, selling an estimated $4.99K and leaving 4,886 shares worth $1.72M. The position accounts for 0.21% of the portfolio, ranked #64.
Claret Asset Management first reported a position in AMGN in Q4 2017 and has held it in 21 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Claret Asset Management held 4,886 shares of Amgen worth $1.72M as of Q1 2026.
- Claret Asset Management sold 14 Amgen shares in Q1 2026, an estimated $4.99K.
- Amgen made up 0.21% of Claret Asset Management's portfolio in Q1 2026, its #64 holding.
- Claret Asset Management first reported a position in Amgen in Q4 2017 and has held it in 21 quarters since.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.